With rising costs, regulations and competitive pressure, it’s more challenging than ever to grow revenue. As the leader in Rx returns — serving pharma manufacturers, hospitals, long-term care and retailers — Inmar Intelligence collects 30+ million pounds of Rx products annually. We offer comprehensive solutions to help drive efficiency and improve processes, empowering brands to inform, interact with and inspire patients. The results? Revenue growth, increased profitability and strengthened brand equity.
INMAR ACQUIRES QUALANEX, LLC, ACCELERATING THE DIGITIZATION OF RX RETURNS
This acquisition will drive the level and pace of innovation and digital transformation that are critical to meet the demands of today’s marketplace. The combination of our two organizations will provide an improved experience for all in the reverse distribution ecosystem: Hospitals, Retailers, Wholesalers and Manufacturers, as we focus on improving efficiency, accuracy and turnaround times. Together, our two Rx facilities, Inmar’s Grand Prairie location and Qualanex’s Libertyville site, will offer numerous benefits including important protection as part of our disaster recovery plan.
Manufacturer Pharmaceutical Returns
Our comprehensive pharmaceutical returns management solution for manufacturers drives increased efficiency through state-of-the-art technologies including:
- One Touch Advantage® processing
- Online returns management
- A Returns Authorization (RA) tool
Our solution ensures your processes for returns and disposition are compliant, and delivers:
- Industry-leading accuracy
- Automation
- Policy Management
- Reconciliation
- Documentation
- Benchmarking
OneRecall™ for Pharmaceutical Manufacturers
We help protect manufacturer brands through our professional recall consulting, planning and regulatory services and end-to-end recall execution. We guide companies through all the steps of a recall event — helping minimize impact through comprehensive process optimization, notification/response, product retrieval, compliant disposition, and performance analytics for regulatory reporting and process improvement.
Sponsored Consumer Drug Take-Back
As the diversion, abuse and improper disposal of prescription drugs continue to threaten public health, state governments across the country are requiring pharmaceutical manufacturers to help execute, and pay for, consumer drug take-back programs. We leverage our resources and systems in place, as well as our relationships with more than 50,000 pharmacies and health systems throughout the United States, to ensure that subscribing manufacturers are able to fully comply with each state’s program requirements — and do so with cost certainty and containment.
PrescriptiveIQ™ for Healthcare
Inmar's PrescriptiveIQ™ for Healthcare provides pharmaceutical manufacturers with affordable, actionable brand business intelligence detailing product, physician, payer and patient activity across the Healthcare Ecosystem. It is a SaaS offering that delivers advanced commercial analytics with unmatched frequency via insight driven dashboards.